| Due Diligence for Asset Managers |
|---|
|
Analyze the public filings of asset managers Dive into the EDGAR, IAPD, CAFR source data |
|
⚲
|
| Keyboard |
| MAIA Biotechnology Inc | |
|---|---|
| Ticker | MAIA |
| CIK # | 0001878313 |
| CUSIP | 552641102 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 444 West Lake Street, Suite 1700, Chicago, IL 60606 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| MAIA Biotechnology Inc | 2026-01-05 | 1.5 M | Exemption: 506(b) · Remaining: $490,211 · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001878313] | 10-K | |
| [0001878313] | 10-Q | |
| [0001878313] | 3 | |
| [0001878313] | 4 | |
| [0001878313] | 8-K | |
| [0001878313] | D | |
| [0001878313] | SC 13D | |
| [0001878313] | SC 13G |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed | % Owned |
|---|---|---|---|
| Solas Capital Management LLC | MAIA Biotechnology Inc | [2026-05-15] | 0.0 |
| FGMK Business Holdings LLC | MAIA Biotechnology Inc | [2025-03-03] | 0.0 |
| Louie NGAR Yee | MAIA Biotechnology Inc | [2024-10-25] | 81946.5 |
| Vitoc Vlad | MAIA Biotechnology Inc | [2024-10-25] | 819413.29 |
| Louie NGAR Yee | MAIA Biotechnology Inc | [2023-02-14] | 0.59 |
| Gryaznov Sergei | MAIA Biotechnology Inc | [2023-02-14] | 7.66 |
| Vitoc Vlad | MAIA Biotechnology Inc | [2023-02-14] | 23.98 |
| Smith Stan | MAIA Biotechnology Inc | [2022-08-10] | 6.0 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Theagene Jean-Manasse
Options · derivative
|
2025-12-31 | Grant | 24,060 | $0.00 | |
|
Luput Cristian
Options · derivative
|
2025-12-31 | Grant | 25,206 | $0.00 | |
|
Louie Ngar Yee
Options · derivative
|
2025-12-31 | Grant | 29,789 | $0.00 | |
|
Guerrero Ramiro
Options · derivative
|
2025-12-31 | Grant | 24,060 | $0.00 | |
|
Chaouki Steven M
Options · derivative
|
2025-12-31 | Grant | 24,633 | $0.00 | |
|
Smith Stan
Options · derivative
|
2025-12-31 | Grant | 29,216 | $0.00 | |
|
Chaouki Steven M
Common Stock
|
2025-12-22 | Buy | 40,849 | $1.22 | 49,836 |
|
Smith Stan
Stock Options · derivative
|
2025-12-22 | Buy | 57,189 | $1.36 | 77,777 |
|
Chaouki Steven M
Stock Options · derivative
|
2025-12-22 | Buy | 40,849 | $1.36 | 55,555 |
|
Louie Ngar Yee
Common Stock
|
2025-12-22 | Buy | 81,699 | $1.22 | 99,673 |
|
Louie Ngar Yee
Stock Options · derivative
|
2025-12-22 | Buy | 81,699 | $1.36 | 111,111 |
|
Smith Stan
Common Stock
|
2025-12-22 | Buy | 57,189 | $1.22 | 69,771 |
|
Smith Stan
Common Stock
|
2025-12-05 | Buy | 4,580 | $1.19 | 5,450 |
|
Smith Stan
Common Stock
|
2025-12-05 | Buy | 4,580 | $1.20 | 5,496 |
|
Smith Stan
Common Stock
|
2025-12-05 | Buy | 4,580 | $1.20 | 5,496 |
|
Luput Cristian
Common Stock
|
2025-11-28 | Buy | 18,145 | $1.11 | 20,141 |
|
Common Stock
|
2025-11-28 | Buy | 50,000 | $1.14 | 57,000 |
|
Vitoc Vlad
Common Stock
|
2025-11-28 | Buy | 50,000 | $1.14 | 57,000 |
|
Smith Stan
Common Stock
|
2025-11-26 | Buy | 15,000 | $1.04 | 15,600 |
|
Common Stock
|
2025-11-26 | Buy | 22,000 | $1.05 | 23,100 |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 33 | 13,152,238 |
| 2025-12-31 | 26 | 2,516,804 |
| 2025-09-30 | 19 | 2,373,804 |
| 2025-06-30 | 21 | 2,283,471 |
| 2025-03-31 | 21 | 1,477,270 |
| 2024-12-31 | 21 | 1,390,935 |
| 2024-09-30 | 18 | 1,467,323 |
| 2024-06-30 | 22 | 1,788,147 |
| 2024-03-31 | 21 | 681,140 |
| 2023-12-31 | 23 | 808,483 |
| 2023-09-30 | 15 | 300,772 |
| 2023-06-30 | 13 | 321,938 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| PVG Asset Management Corp | [2026-06-30] | SOLE | 915 | 34,135 |
| Wealth Enhancement Advisory Services LLC | [2026-06-30] | SOLE | 0 | 14,800 | Prev | Page 1 | Next |